What is Elixir Research Group?
Elixir Research Group is dedicated to advancing pharmaceutical, biotechnology, and medical device development through high-quality clinical trial subject care. Operating within the expansive medical hub of Houston, the company emphasizes meeting protocol requirements, adhering to timelines, and achieving recruitment goals for its sponsors. Their commitment to fostering long-lasting partnerships highlights a client-centric approach to clinical research services.
How much funding has Elixir Research Group raised?
Elixir Research Group has raised a total of $57K across 1 funding round:
Debt
$57K
Debt (2021): $57K with participation from PPP
What's next for Elixir Research Group?
With the infusion of substantial expansion capital, Elixir Research Group is poised for significant scaling. The company's focus on clinical trial subject care and sponsor collaboration, particularly within the thriving Houston medical ecosystem, suggests a strategic trajectory aimed at enhancing its capabilities and market reach. This funding is expected to fuel operational expansion, potentially leading to increased trial capacity and the adoption of new technologies to further streamline research processes.
See full Elixir Research Group company page
